Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Credit
Loan against securities and Personal loan
Manage alerts
Active alerts for Anthem Biosciences
Add new alert
ANTHEM •
NSE
Anthem Biosciences
₹888.30
0.00 (0.00%)
1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
Overview
Technicals
News
Events
ScoutQuest •
11 hours ago
Anthem Biosciences commences Rs 1,200 crore Unit 4 expansion across 30 acres, targeting a $10 billion market. It is investing in peptides, RNAi, and ADCs, while actively reducing China supply dependency to ~20%.
Livesquawk •
2 days ago
Anthem reported a Q2 standalone net profit of ₹221M, up from ₹198.4M year-on-year.
ScoutQuest •
2 days ago
Anthem Biosciences' H1 FY27 revenue fell 7.2% YoY to ₹10,123 Mn, with CRDMO revenue dropping 7.6% to ₹8,501 Mn. For H1 FY27, EBITDA margin stood at 46.2%, PAT margin at 30.2%, and net cash reached ₹15,380 Mn.
BSE •
1 week ago
Anthem Biosciences board will meet on November 3, 2026, to consider and approve Q2 and half-year financial results. The trading window for dealing in company shares remains closed from October 1 until November 5, 2026.
Livesquawk •
4 weeks ago
Anthem recorded a BSE block trade valued at Rs 249.9 crore for approximately 3,000,000 shares. The block trade was executed at a price of Rs 833 per share.
ScoutQuest •
2 months ago
Anthem Biosciences finalizes INR 1,276.8M settlement under upside sharing arrangement. Settlement includes divestment by Viridity Tone LLP and three principal shareholders.
Livesquawk •
3 months ago
Jefferies initiates Buy on Anthem Biosciences with ₹1,050 target due to strong CRDMO capabilities. Firm projects ~40% EBITDA margin, ~25% ROCE, and 18–20% earnings CAGR driving growth.
Moneycontrol •
3 months ago
Anthem Biosciences shares rise 2.1%, trading at Rs 871 on August 11, 2026. The gain is attributed to quarterly performance, dividend announcement, and AGM filings.
Moneylife •
3 months ago
Anthem Biosciences reports weak Q1 due to delivery timing issues. Despite weak Q1, the company's order book remains strong.
ScoutQuest •
4 months ago
Anthem Biosciences rebounds 4% from lows after management comments on FY27 growth targets. Management sees India manufacturing providing 5-10x cost advantage over US.